热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PerCP/Cyanine5.5 anti-mouse CD8a Antibody
产品名称：
PerCP/Cyanine5.5 anti-mouse CD8a Antibody
产品类别：
抗体
产品编号：
100733
产品应用：
100733
[价格]
规格 价格 库存
25µg ￥ 1044 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/mL
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is <?1.0 ?g per million cells in 100 ?L volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Additional Product Notes

BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  30. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  2. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  3. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  4. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  5. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  6. Yoon J et al. 2018. J Vis Exp. -141 . PubMed
  7. Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
  8. Garber C, et al. 2019. Nat Neurosci. 1.802777778. PubMed
  9. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  10. Zheng X, et al. 2019. PLoS Pathog. 15:e1008036. PubMed
  11. Lang J, et al. 2020. Nat Commun. 11:1338. PubMed
  12. Hudson WH, et al. 2020. Immunity. 51(6):1043-1058.e4.. PubMed
  13. Murata A, et al. 2020. Front Immunol. 11:775. PubMed
  14. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  15. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  16. Platt DJ, et al. 2021. Cell Reports. 35(6):109113. PubMed
  17. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  18. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  19. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  20. Zhang R, et al. 2019. Cell Rep. 28:2647. PubMed
  21. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  22. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  23. Sawada J, et al. 2021. Am J Pathol. 191:396. PubMed
  24. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  25. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  26. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  27. Aldon Y, et al. 2020. J Immunol. 204:903. PubMed
  28. Alotaibi F, et al. 2021. Front Immunol. 11:584937. PubMed
  29. Pack AD, et al. 2021. Cell Reports. 36(8):109586. PubMed
  30. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  31. Chen L, et al. 2020. Cancer Immunol Res. 0.457638889. PubMed
  32. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  33. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  34. Sultan H, et al. 2018. Cancer Immunol Res. 6:617. PubMed
  35. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  36. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  37. Juul-Madsen K, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  38. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  39. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
  40. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  41. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  42. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  43. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  44. Hong JY, et al. 2020. Cell. 180(5):847-861. PubMed
  45. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
  46. Mizraji* G, et al. 2013. J Vis Exp. 77: 50388. PubMed
  47. Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed
  48. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  49. Solanki A, et al. 2018. Development. 145. PubMed
  50. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
  51. Green DP, et al. 2019. Neuron. 101:412. PubMed
  52. Terashima Y, et al. 2020. Nat Commun. 11:609. PubMed
  53. Smith AS, et al. 2022. J Immunother Cancer. 10:. PubMed
  54. Agrawal M, et al. 2021. Cells. 10:. PubMed
  55. Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed
  56. Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
  57. Ruhland MK, et al. 2020. Cancer Cell. 37(6):786-799.e5. PubMed
  58. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  59. Holvoet B, et al. 2015. Stem Cell Reports. 5: 1183-1195. PubMed
  60. Dekhtiarenko I, et al. 2013. J Immunol. 190:3399. PubMed
  61. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  62. Hildebrand KM, et al. 2021. PLoS One. 16:e0253864. PubMed
  63. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  64. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  65. H?nes J, et al. 2017. Sci Rep. . 10.1038/s41598-017-15866-9. PubMed
  66. Xu J et al. 2018. Cell. 173(3):762-775 . PubMed
  67. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  68. Ren J, et al. 2019. PLoS Biol. 17:e3000270. PubMed
  69. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  70. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  71. Tondini E, et al. 2022. NPJ Vaccines. 7:64. PubMed
  72. Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed
  73. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  74. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  75. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  76. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  77. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  78. Pilzecker B, et al. 2016. Nucleic Acids Res. 44: 4734 - 4744. PubMed
  79. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  80. Novince CM, et al. 2017. Sci Rep. 7:5747. PubMed
  81. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  82. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  83. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  84. Bourque J, et al. 2021. Heliyon. 7:e08311. PubMed
  85. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  86. Bullard BL, et al. 2022. NPJ Vaccines. 7:65. PubMed
  87. Dutow P, et al. 2014. J Infect Dis. 209:1269. PubMed
  88. White C, et al. 2015. J Immunol. 194:697. PubMed
  89. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  90. Chung L et al. 2018. Cell host & microbe. 23(2):203-214 . PubMed
  91. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
  92. Wu J et al. 2019. Immunity. 50(5):1218-1231 . PubMed
  93. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  94. Sun Y, et al. 2022. Mol Ther Oncolytics. 25:160. PubMed
  95. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  96. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  97. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  98. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  99. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  100. Parayath NN, et al. 2020. Nat Commun. 4.680555556. PubMed
  101. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  102. Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed
  103. Karandikar SH, et al. 2019. Anal Chem. 91:3405. PubMed
  104. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  105. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  106. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  107. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  108. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  109. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  110. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  111. Shi R, et al. 2019. J Cancer. 10:367. PubMed
  112. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  113. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  114. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  115. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  116. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  117. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  118. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  119. Dekhtiarenko I, et al. 2016. PLoS Pathog. 12:e1006072. PubMed
  120. Tang Y, et al. 2019. Nat Commun. 10:4157. PubMed
  121. Lee SC et al. 2018. Cancer cell. 34(2):225-241 . PubMed
  122. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  123. Mezzapelle R, et al. 2021. EMBO Mol Med. 13:e12344. PubMed
  124. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  125. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  126. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  127. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  128. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  129. Hartwig S, et al. 2014. PLoS One. 9:90720. PubMed
  130. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  131. Highton AJ, et al. 2019. Wellcome Open Res. 4:78. PubMed
  132. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  133. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  134. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  135. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  136. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  137. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  138. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  139. Bennion BG, et al. 2019. J Virol. 93. PubMed
  140. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  141. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  142. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  143. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  144. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  145. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  146. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  147. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  148. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  149. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  150. Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed
  151. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  152. Borkner L, et al. 2017. J Immunol. 10.4049/jimmunol.1602115. PubMed
  153. Hendrikx S et al. 2019. Cell reports. 26(5):1227-1241 . PubMed
  154. Field CS, et al. 2020. Cell Metab. 31:422. PubMed
  155. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  156. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  157. Cohen MA, et al. 2020. Cell Stem Cell. 26(4):579-592. PubMed
  158. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  159. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  160. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  161. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  162. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  163. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  164. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  165. Siolas D, et al. 2021. Cell Reports. 36(8):109578. PubMed
  166. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  167. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  168. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  169. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  170. S?wen P et al. 2018. eLife. 7 pii: e41258. PubMed
  171. White JP et al. 2018. Cell. 175(5):1198-1212 . PubMed
  172. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  173. RL M, et al. 2015. Proc Natl Acad Sci U S A. 112:6506-6514. PubMed
  174. Gorman M, et al. 2016. J Virol. 90: 8212 - 8225. PubMed
  175. Goc J, et al. 2021. Cell. :. PubMed
  176. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  177. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  178. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  179. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  180. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  181. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  182. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  183. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  184. Strattan E, et al. 2020. Frontiers in Immunology. 2.131944444. PubMed
  185. Wolf Y, et al. 2019. Cell. 179:219. PubMed
  186. Mohammed RN, et al. 2019. Sci Rep. 4.185416667. PubMed
  187. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
RRID
AB_2075239 (BioLegend Cat. No. 100733) AB_2075238 (BioLegend Cat. No. 100734)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线